You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />
an al ge sics 9%<br />
psychoanaleptics 6%<br />
Lead ing Dose Forms:<br />
cap sules 26%<br />
coated tab lets 23%<br />
tab lets 22%<br />
liq uids 11%<br />
med i cal dress ings 9%<br />
UZBEKISTAN<br />
LEK<br />
Full Name: Lek d.d., Rep re sen ta tive Of fice.<br />
Street Ad dress: 700000 Tashkent, 3, L. To lstoy<br />
street, ap. 14-15<br />
Tel: +998 71 137 00 38<br />
Fax: +998 71 137 06 92<br />
Email: lektash@globalnet.uz<br />
De scrip tion: Rep re sen ta tive of fice. Re searcher,<br />
pro moter. Prod uct ranges in clude: phar ma ceu ti -<br />
cal prod ucts (branded, unbranded, pre scrip tion,<br />
non-pre scrip tion), hos pi tal pharmaceuticals.<br />
Established 1995.<br />
Con tacts (Pharm): Chair man: Alisher<br />
Iskhakov; Gen eral Con tact: Alisher Iskhakov<br />
VENEZUELA<br />
NOVARTIS<br />
Full Name: Novartis de Ven e zuela S.A.<br />
Postal Ad dress: Apartado 68097, Ca ra cas<br />
1062-A<br />
Street Ad dress: 3ra. Transversal de Los Ruices,<br />
Edificio Novartis, Urb. Los Ruices, Ca ra cas 1071<br />
Tel: +58 212 239-40-11<br />
Fax: +58 212 239-10-68<br />
Home Page: www.novartis.com.ve<br />
De scrip tion: Im porter, dis trib u tor, pro moter,<br />
de vel oper, sales/detailer. Im ports, dis trib utes,<br />
pro motes for other com pa nies. Prod uct ranges in -<br />
clude: phar ma ceu ti cal prod ucts (branded,<br />
unbranded, pre scrip tion, non-pre scrip tion), hos -<br />
pi tal pharmaceuticals, oph thal mic prod ucts. Es -<br />
tab lished 1997. 362 phar ma ceu ti cal em ploy ees in<br />
2007. Di vi sions in clude: Pharma; Sandoz; OTC;<br />
Ciba Vision.<br />
Rep re sen ta tives/De tail ers (Pharm, Num -<br />
ber): 220 (2007)<br />
Con tacts (Pharm): Chair man: Cesar Casal;<br />
Com mer cial Op er a tions: Luis Marsicano; Man u -<br />
fac ture: Al ex an der Altamar; Re search &<br />
De vel op ment: Gustavo Rivas<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
Phar ma ceu ti cal Sales: US$ 160-170 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 60-65%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 80-85%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
90-95%<br />
Prin ci pal Prod ucts:<br />
CATAFLAM (antirheumatic non-steroidal)<br />
DIOVAN HCT (an gio ten sin-II an tag o nist com bi na -<br />
tion)<br />
DIOVAN (an gio ten sin-II an tag o nist plain)<br />
VOLTAREN (antirheumatic non-steroidal)<br />
TRILEPTAL (antiepileptic)<br />
Ther a peu tic Range:<br />
anti rheu ma tics sys temic 39%<br />
renin-an gio ten sin sys tem agents 27%<br />
antiepileptics 8%<br />
antiasthma and COPD prod ucts 5%<br />
ophthalmologicals 4%<br />
Lead ing Dose Forms:<br />
coated tab lets 49%<br />
cap sules 15%<br />
liq uids 13%<br />
tab lets 11%<br />
sup pos i to ries 3%<br />
NOVARTIS NU TRI TION<br />
Full Name: Novartis Nu tri tion de Ven e zuela, S.A.<br />
Postal Ad dress: Apartado 80532, Ca ra cas<br />
1080A<br />
Street Ad dress: Calle del Arenal, Edf.Palacio,<br />
Piso 2, Zona La Trin i dad, Mun.Baruta,<br />
Edo.Miranda 1081, Ca ra cas 1081<br />
Tel: +58 212 949-00-00<br />
Fax: +58 212 949-00-59<br />
Home Page: www.novartisnutrition.com<br />
Con tacts (Pharm): Gen eral Con tact: Chris tine<br />
John son<br />
Phar ma ceu ti cal Sales: US$ 28-30 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 75-80%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 90-95%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
75-80%<br />
Prin ci pal Prod ucts:<br />
VOLTAREN TOPICO (antirheumatic top i cal)<br />
LAMISIL TOPICO (dermatological antifungal)<br />
PARSEL (antimigraine prep a ra tion)<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 223
Change language